Citation Impact
Citing Papers
Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker
2012 Standout
Mitochondrial and Immunoallergic Injury Increase Risk of Positive Drug Rechallenge After Drug-Induced Liver Injury
2010
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans
2016
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
The use of SAMe in chemotherapy-induced liver injury
2018
The risks of PPI therapy
2012
Primary and secondary alterations of neonatal carnitine metabolism
1999
Phenotypic differences in behavior, physiology and neurochemistry between rats selected for tameness and for defensive aggression towards humans
2007 StandoutNobel
Idiopathic pulmonary fibrosis
2017 Standout
Changing etiologies and outcomes of acute liver failure: A perspective from Japan
2011
Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): A critical discussion
2013
Discontinuation of proton pump inhibitors in patients on long‐term therapy: a double‐blind, placebo‐controlled trial
2006
Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies
2015
Using sulfuramidimidoyl fluorides that undergo sulfur(vi) fluoride exchange for inverse drug discovery
2020 StandoutNobel
Trastuzumab-Induced Hepatotoxicity: A Case Report
2013 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Carnitine supplementation of parenterally fed neonates
2000
Inappropriate prescribing of proton pump inhibitors in primary care
2007
Rational Tuning of Fluorobenzene Probes for Cysteine‐Selective Protein Modification
2018 StandoutNobel
Targeted Covalent Inhibitors for Drug Design
2016
Metabolism and bioactivation of famitinib, a novel inhibitor of receptor tyrosine kinase, in cancer patients
2012
Molecular Docking and Structure-Based Drug Design Strategies
2015 Standout
ProTox-II: a webserver for the prediction of toxicity of chemicals
2018 Standout
PubChem 2023 update
2022 Standout
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
2016 Standout
Rational Tuning of Fluorobenzene Probes for Cysteine‐Selective Protein Modification
2018 StandoutNobel
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
The resurgence of covalent drugs
2011
A Heck–Matsuda Process for the Synthesis of β‐Arylethenesulfonyl Fluorides: Selectively Addressable Bis‐electrophiles for SuFEx Click Chemistry
2016 StandoutNobel
Biomedical Importance of Indoles
2013 Standout
A Heck–Matsuda Process for the Synthesis of β‐Arylethenesulfonyl Fluorides: Selectively Addressable Bis‐electrophiles for SuFEx Click Chemistry
2016 StandoutNobel
Palladium‐Catalyzed Fluorosulfonylvinylation of Organic Iodides
2017 StandoutNobel
Palladium‐Catalyzed Fluorosulfonylvinylation of Organic Iodides
2017 StandoutNobel
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
The Essential Medicinal Chemistry of Curcumin
2017 Standout
ESPGHAN and ESPEN Guidelines Paediatric Parenteral Nutrition ‐ Annex: List of Products
2005 Standout
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
2015 Standout
Works of Anna Niklasson being referenced
Dyspeptic Symptom Development After Discontinuation of a Proton Pump Inhibitor: A Double-Blind Placebo-Controlled Trial
2010
Overuse of acid suppressive therapy in hospitalised patients with pulmonary diseases
2003
Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals
2008
Parenteral nutrition in preterm neonates with and without carnitine supplementation
1990
Oral Medications With Significant Hepatic Metabolism at Higher Risk for Hepatic Adverse Events
2009
Carnitine in Maternal and Neonatal Plasma*
1985